AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimnom-M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Acinom Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimnom-M 1mg/500mg Tablet

Diabexe Duo 1mg/500mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabexe Duo should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's one element of a comprehensive plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with a quick-acting glucose source (e.g., sugary foods, fruit juice). Alcohol increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a potential consequence for some. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor about any prior heart conditions before starting treatment, as it may not be appropriate. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring and periodic blood tests to check blood cell counts and liver function are recommended.

Uses of Glimnom-M 1mg/500mg Tablet

Managing Type 2 diabetes

Major Benefits of Glimnom-M 1mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume the Glimnom-M 1mg/500mg tablet with a meal.

Common Side effects of Glimnom-M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimnom-M 1mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glimnom-M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

How Glimnom-M 1mg/500mg Tablet works:

Glimnom-M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimnom-M 1mg/500mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimnom-M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Lactation and Glimnom-M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimnom-M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimnom-M 1mg/500mg tablets. Physician consultation is essential. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimnom-M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glimnom-M 1mg/500mg tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe liver disease.

What if you forget to take Glimnom-M 1mg/500mg Tablet :

Should you forget a Glimnom-M 1mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimnom-M 1mg/500mg Tablet

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Glimnom-M 1mg/500mg Tablet

Store this medication in its original, tightly sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Glimnom-M 1mg/500mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare but potentially dangerous side effect is particularly concerning for individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms may present as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms develop, discontinue Glimnom-M 1mg/500mg tablet use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimnom-M 1mg/500mg tablets, manage type 2 diabetes mellitus (DM) in adults. This dual therapy enhances blood sugar control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin acts by decreasing hepatic glucose production and boosting insulin responsiveness. This formulation is unsuitable for type 1 DM.
Glimnom-M 1mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Indeed, prolonged Glimnom-M 1mg/500mg Tablet consumption can lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Left unaddressed, this deficiency may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive strategies proposed by some studies include supplemental Vitamin B12 at least annually.
Indeed, Glimnom-M 1mg/500mg tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. It's advisable to always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Consuming alcohol concurrently with Glimnom-M 1mg/500mg tablets is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Furthermore, this combination elevates the likelihood of lactic acidosis.
Glimnom-M 1mg/500mg Table...
34
MRP 42
19% off